Compound property enhancement by virtual compound synthesis
暂无分享,去创建一个
Masakazu Sekijima | Nobuaki Yasuo | Naoki Arai | Shunsuke Yoshikawa | Ryunosuke Yoshino | M. Sekijima | Nobuaki Yasuo | Ryunosuke Yoshino | N. Arai | Shunsuke Yoshikawa
[1] K. Stewart,et al. Drug Guru: a computer software program for drug design using medicinal chemistry rules. , 2006, Bioorganic & medicinal chemistry.
[2] Xing-Jie Liang,et al. Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection. , 2010, Drug discovery today.
[3] C. Wermuth,et al. Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998) , 1998 .
[4] Peter Ertl,et al. JSME: a free molecule editor in JavaScript , 2013, Journal of Cheminformatics.
[5] M. Sekijima,et al. Pharmacophore Modeling for Anti-Chagas Drug Design Using the Fragment Molecular Orbital Method , 2015, PloS one.
[6] I M Kapetanovic,et al. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. , 2008, Chemico-biological interactions.
[7] Daisuke Kihara,et al. An iterative compound screening contest method for identifying target protein inhibitors using the tyrosine-protein kinase Yes , 2017, Scientific Reports.
[8] J. Willmann,et al. Molecular imaging in drug development , 2008, Nature Reviews Drug Discovery.
[9] I. Hayakawa,et al. Synthesis and Antibacterial Activities of Substituted 7-Oxo-2, 3-dihydro-7H-pyrido [1, 2, 3-de] [1, 4] benzoxazine-6-carboxylic Acids , 1984 .
[10] J. Powers,et al. Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Robert J. Jilek,et al. AllChem: generating and searching 1020 synthetically accessible structures , 2007, J. Comput. Aided Mol. Des..
[12] Robert D. Clark,et al. Virtual Compound Libraries: A New Approach to Decision Making in Molecular Discovery Research , 1998, J. Chem. Inf. Comput. Sci..
[13] Kimito Funatsu,et al. A Novel Approach to Retrosynthetic Analysis Using Knowledge Bases Derived from Reaction Databases , 1999, J. Chem. Inf. Comput. Sci..
[14] T. Ishida,et al. In silico, in vitro, X-ray crystallography, and integrated strategies for discovering spermidine synthase inhibitors for Chagas disease , 2017, Scientific Reports.
[15] S S Adams,et al. The Propionic Acids: A Personal Perspective , 1992, Journal of clinical pharmacology.
[16] G. V. Paolini,et al. Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.
[17] Lorenz C. Blum,et al. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. , 2009, Journal of the American Chemical Society.
[18] W. Guida,et al. The art and practice of structure‐based drug design: A molecular modeling perspective , 1996, Medicinal research reviews.
[19] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[20] Charles C. Persinger,et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.
[21] Zhengwei Peng,et al. Very large virtual compound spaces: construction, storage and utility in drug discovery. , 2013, Drug discovery today. Technologies.
[22] Kun-Yi Hsin,et al. Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target , 2015, Scientific Reports.
[23] Asher Mullard. New drugs cost US$2.6 billion to develop , 2014, Nature Reviews Drug Discovery.